Ventripoint Diagnostics Ltd. – Trademark Portfolio
Entity Type: 99
Ventripoint Diagnostics Ltd. has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 100% registration rate. The portfolio includes marks such as KBR and VMS. Filings span 3 Nice Classification classes, with the highest activity in Class 9 (Computers & Electronics) and Class 10 (Medical Apparatus). This trademark owner is based in Toronto, Ontario.
2 Sheppard Ave East, Suite 605
Toronto, Ontario M2N5Y7 , CA
Showing of trademarks Trademarks
Trademark Classifications
Ventripoint Diagnostics Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Ventripoint Diagnostics Ltd. have?
Ventripoint Diagnostics Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Ventripoint Diagnostics Ltd. file in?
Ventripoint Diagnostics Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Ventripoint Diagnostics Ltd.'s most well-known trademarks?
Ventripoint Diagnostics Ltd.'s registered trademark portfolio includes well-known marks such as KBR and VMS. These are among 3 currently registered trademarks in the portfolio.
What is Ventripoint Diagnostics Ltd.'s trademark registration success rate?
Ventripoint Diagnostics Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.